Document:

Exhibit 10.1

 

FIRST AMENDMENT

TO THE

PHASERX, INC. 2016 LONG-TERM INCENTIVE
PLAN

 

This FIRST
AMENDMENT TO THE PhaseRx, Inc. 2016 Long-Term Incentive Plan (this
“Amendment”), dated as of March 23,  2017, is made and entered into by PhaseRx, Inc., a
Delaware corporation (the “Company”). Terms used in this Amendment with initial capital letters
that are not otherwise defined herein shall have the meanings ascribed to such terms in the PhaseRx, Inc. 2016 Long-Term
Incentive Plan (the “Plan”).

 

WHEREAS, Article
9 of the Plan provides that the Board of Directors of the Company (the “Board”) may amend the Plan at
any time and from time to time; and

 

WHEREAS, the
Board desires to amend the Plan to revise its definition of “Fair Market Value” for purposes of awards granted pursuant
to the Plan, with such revised definition to be effective as of the date of stockholder approval of this Amendment.

 

NOW, THEREFORE,
in accordance with Article 9 of the Plan, the Company hereby amends the Plan, effective as of the date of stockholder approval
of this Amendment, as follows:

 

1.             Section 2.22 of the Plan is hereby amended by deleting said section in its entirety and substituting in lieu thereof the
following new Section 2.22:

 

2.22         
“Fair Market Value” means, as of a particular date, (a) if the shares of Common Stock are listed
on any established national securities exchange, the closing sales price per share of Common Stock on the consolidated transaction
reporting system for the principal securities exchange for the Common Stock on that date or, if there shall have been no such sale
so reported on that date, on the last preceding date on which such a sale was so reported; (b) if the shares of Common Stock are
not so listed, but are quoted on an automated quotation system, the closing sales price per share of Common Stock reported on the
automated quotation system on that date or, if there shall have been no such sale so reported on that date, on the last preceding
date on which such a sale was so reported; (c) if the Common Stock is not so listed or quoted, the mean between the closing bid
and asked price on that date or, if there are no quotations available for such date, on the last preceding date on which such quotations
shall be available, as reported by the OTC Bulletin Board operated by the Financial Industry Regulation Authority, Inc. or the
OTC Markets Group Inc., formerly known as Pink OTC Markets Inc.; or (d) if none of the above is applicable, such amount as may
be determined by the Committee (acting on the advice of an Independent Third Party, should the Committee elect in its sole discretion
to utilize an Independent Third Party for this purpose), in good faith, to be the fair market value per share of Common Stock.
The determination of Fair Market Value shall, where applicable, be in compliance with Section 409A of the Code.

 

3.           
Except as expressly amended by this Amendment, the Plan shall continue in full force and effect in accordance with the provisions
thereof.

 

 

* * * * * * * *

 

     

     

    

 

IN WITNESS WHEREOF, the Company has
caused this Amendment to be duly executed as of the date first written above.

 

 

	 	PHASERX, INC.
	 	 
	 	By: 	/s/ Robert W. Overell
	 	Name:  	Robert W. Overell
	 	Title:	President and CEO

 

 

Signature
Page to

First
Amendmenteigr-ex101_419.htm

 

Exhibit 10.1

Eiger BioPharmaceuticals, Inc. 

Non-Employee Director Compensation Policy

Adopted by the board: September 3, 2013

Amended: April 12, 2017

Each member of the Board of Directors (the “Board”) who is not also serving as an employee of Eiger BioPharmaceuticals, Inc. (“Eiger”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Non-Employee Director Compensation Policy for his or her Board service on and following the date of the underwriting agreement between Eiger and the underwriters managing the initial public offering of  the common stock of Eiger (the “Common Stock”), pursuant to which the Common Stock is priced in such initial public offering (the “Effective Date”).  This policy is effective as of the Effective Date and may be amended at any time in the sole discretion of the Board or the Compensation Committee of the Board.

Annual Cash Compensation

The annual cash compensation amount set forth below is payable in equal quarterly installments, payable in arrears on the last day of each fiscal quarter in which the service occurred. If an Eligible Director joins the Board or a committee of the Board at a time other than effective as of the first day of a fiscal quarter, each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal year, with the pro-rated amount paid for the first fiscal quarter in which the Eligible Director provides the service, and regular full quarterly payments thereafter. All annual cash fees are vested upon payment. 

	
1.
	
Annual Board Service Retainer: 

	
 
	
a.
	
All Eligible Directors: $40,000

	
 
	
b.
	
Chairman of the Board Service Retainer (in addition to Eligible Director Service Retainer): $30,000 

2.Annual Committee Member Service Retainer:

	
 
	
a.
	
Member of the Audit Committee: $7,500

	
 
	
b.
	
Member of the Compensation Committee: $5,000

	
 
	
c.
	
Member of the Nominating & Governance Committee: $3,750

	
3.
	
Annual Committee Chair Service Retainer (in addition to Committee Member Service Retainer):

	
 
	
a.
	
Chairman of the Audit Committee: $15,000

	
 
	
b.
	
Chairman of the Compensation Committee: $10,000

	
 
	
c.
	
Chairman of the Nominating & Governance Committee: $7,500

1.

 

144060041 v4 

 

Equity Compensation

The equity compensation set forth below will be granted under the Eiger Corporation 2013 Equity Incentive Plan (the “Plan”), subject to the Eiger stockholders’ approval of the Plan. All stock options granted under this policy will be nonstatutory stock options, with an exercise price per share equal to 100% of the Fair Market Value (as defined in the Plan) of the underlying Common Stock on the date of grant, and a term of ten years from the date of grant (subject to earlier termination in connection with a termination of service as provided in the Plan, provided that upon a termination of service other than for cause, the post-termination exercise period will be three years from the date of termination, subject to the original term of the option).

1.Initial Grant: On the date of the Eligible Director’s initial election to the Board, for each Eligible Director who is first elected to the Board following the Effective Date (or, if such date is not a market trading day, the first market trading day thereafter), the Eligible Director will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a stock option for 25,000 shares (the “Initial Grant”).  The shares subject to each Initial Grant will vest in equal monthly installments over a three year period such that the option is fully vested on the third anniversary of the date of grant, subject to the Eligible Director’s Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan).

2.Annual Grant: At the Compensation Committee meeting held in January,  February or March of each year for the purpose of granting executives annual equity incentive awards following the Effective Date or, if a Compensation Committee meeting is not held by the end of February of any year, on the last trading date in March of such year following the Effective Date, for each Eligible Director who continues to serve as a non-employee member of the Board (or who is first elected to the Board at such annual stockholder meeting), the Eligible Director will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a stock option for 10,000 shares (the “Annual Grant”). In addition, each Eligible Director who is first elected to the Board following the Effective Date and other than at an annual stockholder meeting will be automatically, and without further action by the Board or Compensation Committee of the Board, granted an Annual Grant, pro rated for the number of months remaining until the next annual stockholder meeting. The shares subject to the Annual Grant will vest over one year in twelve equal monthly installments subject to the Eligible Director’s Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan). 

3.Eligible Directors serving on the Board on the Effective Date:  Unless otherwise provided by the Board, each Eligible Director who is serving on the Board on the Effective Date will be granted a stock option for 10,000 shares that will vest over one year in twelve equal monthly installments subject to the Eligible Director’s Continuous Service (as defined in the Plan) through such vesting date.

2.

 

144060041 v4Exhibit
10.1

 

AMENDED
AND RESTATED EMPLOYMENT AGREEMENT

 

AMENDED
AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of March 10, 2017, between LONG ISLAND ICED
TEA CORP., a Delaware corporation having its principal office at 116 Charlotte Avenue, Hicksville, NY 11801 (“Company”),
and PHILIP THOMAS, residing at the address on file with the Company (“Executive”).

 

WHEREAS,
the Company and Executive are party to that certain Employment Agreement, dated as of May 27, 2015 (the “Original Agreement”),
pursuant to which Executive is currently employed as Chief Executive Officer of the Company; and

 

WHEREAS,
the Company and Executive desire to amend and restate the Original Agreement on the terms, conditions and provisions hereinafter
set forth.

 

NOW,
THEREFORE, in consideration of the mutual promises, terms, covenants and conditions set forth herein and the performance of each,
the parties hereby agree as follows:

 

1.
Employment, Duties and Acceptance.

 

1.1.
General. During the Term (as defined in Section 2), the Company shall employ Executive in the position of Chief Executive
Officer of the Company and such other positions as shall be given to Executive by the Board of Directors of the Company (the “Board”).
The Company also shall cause Executive to be appointed to comparable offices at the Company’s subsidiaries. All of Executive’s
powers and authority in any capacity shall at all times be subject to the direction and control of the Board. The Board may assign
to Executive such management and supervisory responsibilities and executive duties for the Company or any subsidiary of the Company,
including serving as an executive officer and/or director of any subsidiary, as are consistent with Executive’s then current
status and position with the Company. The Executive’s duties shall be similar to those customarily performed by comparable
officers of similar companies. Without limiting the foregoing, the Company and Executive acknowledge that Executive’s primary
functions and duties shall include working with the board of directors to define long-term strategic initiatives; ensuring that
directives from the Board of Directors are implemented to achieve the Company’s revenue and profitability goals and to maximize
long term shareholder value; and overseeing the operations of the Company and its subsidiaries.

 

    	 		 

    	 		 

    

 

1.2.
Full-Time Position. Executive accepts such employment and agrees to devote substantially all of his business time, energies
and attention to the performance of his duties hereunder. Executive shall not serve as a consultant to, or on boards of directors
of, or in any other capacity to other companies, for profit and not for profit, without the prior consent of the Board. Nothing
herein shall be construed as preventing Executive from making and supervising personal investments, provided they will not interfere
with the performance of Executive’s duties hereunder or violate the provisions of Section 5.4 hereof.

 

1.3.
Location. Executive will perform his duties in or around Hicksville, New York. Executive shall undertake such occasional
travel, within or outside the United States, as is reasonably necessary in the interests of the Company.

 

2.
Term. The term of Executive’s employment hereunder shall commence on the date hereof and shall continue until December
31, 2019 (“Term”) unless terminated earlier as hereinafter provided, or unless extended by mutual written agreement
of the Company and Executive. Unless the Company and Executive have otherwise agreed in writing, if Executive continues to work
for the Company after the expiration of the Term, his employment thereafter shall be under the same terms and conditions provided
for in this Agreement, except that his employment will be on an “at will” basis and the provisions of Sections 4.4
and 4.6(c) shall no longer be in effect.

 

3.
Compensation and Benefits.

 

3.1.
Salary. The Company shall pay to Executive a salary (“Base Salary”) at the annual rate of $250,000.
The Base Salary shall be applied retroactively from January 1, 2017. Executive’s compensation shall be paid in equal, periodic
installments in accordance with the Company’s normal payroll procedures; provided, however, that the first such payment
shall include an amount equal to the difference between the amount Executive was actually paid for services provided between January
1, 2017 and the date of such payment and the amount Executive would have been paid if the Base Salary provided hereunder had been
in effect for all of such period.

 

    	 	2	 

    	 		 

    

 

3.2.
Bonus. The Company shall pay to Executive a lump sum cash bonus of $83,000 promptly after the date hereof; provided that,
the Executive shall repay such cash bonus if, prior to December 31, 2017, Executive terminates his employment without Good Reason
(as defined below) or is terminated by the Company for Cause (as defined below).

 

3.3.
Incentives. Executive shall be eligible to be paid incentive bonuses (“Incentive Bonuses”) from time
to time based on Executive achieving performance goals for Executive and the Company as established by the Compensation Committee
of the Board (“Committee”) in its sole discretion. The Incentive Bonus (if any) will be paid in cash, stock
and/or stock-based awards as per the recommendation of the Committee.

 

3.4.
Stock Options.

 

(a)
Subject to approval by the Committee, the Company shall grant Executive an option (“Option”) to purchase 75,000
shares of the Company’s Common Stock under the Company’s 2015 Long-Term Incentive Equity Plan, at an exercise price
equal to the greater of $4.50 and the Fair Market Value (as defined in the Plan) on the date of grant, with one-third of such
Option vesting immediately and the remaining two-thirds vesting in two equal portions on the first and second anniversary of the
grant date. The duration of the Option shall be for a five-year period from the grant date.

 

(b)
If the Executive’s title is changed from Chief Executive Officer of the Company to Chief Innovation Officer or Head of Business
Development of the Company, at such time, subject to and conditional upon approval by the Committee, the Company will grant Executive
an award under the Company’s 2015 Long-Term Incentive Equity Plan commensurate with appropriate and market benchmarked Head
of Business Development or Chief Innovation Officer remuneration.

 

3.5.
Benefits. Executive shall be entitled to such medical, life, disability and other benefits as are generally afforded to
other executives of the Company, subject to applicable waiting periods and other conditions, as well as participation in all other
company-wide employee benefits, including a defined contribution pension plan and 401(k) plan, as may be made available generally
to executive employees from time to time. In lieu of medical insurance provided by the Company, Executive may request by way of
substitution the sum of up to $1,500 per month for the reimbursement of Executive’s out-of-pocket costs for medical insurance
for Executive and his family.

 

    	 	3	 

    	 		 

    

 

3.6.
Vacation and Sick Days. Executive shall be entitled to twenty (20) days of paid vacation and five (5) days of paid sick
days in each year during the Term and to a reasonable number of other days off for religious and personal reasons in accordance
with customary Company policy.

 

3.7.
Expenses. The Company shall pay or reimburse Executive for all transportation, hotel and other expenses reasonably incurred
by Executive on business trips and for all other ordinary and reasonable out-of-pocket expenses actually incurred by him in the
conduct of the business of the Company against itemized vouchers submitted with respect to any such expenses and approved in accordance
with customary procedures.

 

3.8.
Automobile. The Company shall provide Executive with a suitable leased automobile for business use and shall pay for all
other costs associated with the use of the vehicle, including insurance costs, repairs and maintenance. The Company shall not
be required to expend more than $500 per month for the costs of leasing such automobile. The costs associated with Executive’s
automobile shall be considered taxable income to Executive, except to the extent that it is documented to have been used by him
for business purposes.

 

4.
Termination.

 

4.1.
Death. If Executive dies during the Term, Executive’s employment hereunder shall terminate and the Company shall
pay to Executive’s estate the amount set forth in Section 4.6(a).

 

4.2.
Disability. The Company, by written notice to Executive, may terminate Executive’s employment hereunder if Executive
shall fail because of illness or incapacity to render services of the character contemplated by this Agreement for six (6) consecutive
months. Upon such termination, the Company shall pay to Executive the amount set forth in Section 4.6(a).

 

    	 	4	 

    	 		 

    

 

4.3.
By Company for Cause. The Company, by written notice to Executive, may terminate Executive’s employment hereunder
for Cause. As used herein, “Cause” shall mean: (a) the refusal or failure by Executive to carry out specific
directions of the Board or, if Executive is not the Chief Executive Officer at the time of termination, of the Chief Executive
Officer, which are of a material nature and consistent with his then current status and position, or the refusal or failure by
Executive to perform a material part of Executive’s duties hereunder; (b) the commission by Executive of a material breach
of any of the provisions of this Agreement; (c) fraud or dishonest action by Executive in his relations with the Company or any
of its subsidiaries or affiliates (“dishonest” for these purposes shall mean Executive’s knowingly or
recklessly making of a material misstatement or omission for his personal benefit); or (d) the conviction of Executive of a felony
under federal or state law. Notwithstanding the foregoing, no Cause for termination shall be deemed to exist with respect to Executive’s
acts described in clauses (a) or (b) above, unless the Company shall have given written notice to Executive within a period not
to exceed ten (10) calendar days of the initial existence of the occurrence, specifying the Cause with reasonable particularity
and, within thirty (30) calendar days after such notice, Executive shall not have cured or eliminated the problem or thing giving
rise to such Cause; provided, however, no more than two cure periods need be provided during any twelve-month period. Upon such
termination, the Company shall pay to Executive the amount set forth in Section 4.6(b). The Company shall also pay such amount
to Executive upon his termination of employment without Good Reason, which Executive shall have the right to do on at least thirty
(30) days written notice to the Company.

 

4.4.
By Executive for Good Reason. The Executive, by written notice to the Company, may terminate Executive’s employment
hereunder if a Good Reason exists. For purposes of this Agreement, “Good Reason” shall mean the occurrence
of any of the following circumstances without the Executive’s prior written consent: (a) a substantial and material adverse
change in the nature of Executive’s title, duties and/or responsibilities with the Company that represents a demotion from
his title, duties or responsibilities as in effect immediately prior to such change (such change, a “Demotion”);
(b) material breach of this Agreement by the Company; (c) a failure by the Company to make any payment to Executive when due,
unless the payment is not material and is being contested by the Company, in good faith; or (d) a liquidation, bankruptcy or receivership
of the Company. Notwithstanding the foregoing, no Good Reason shall be deemed to exist (A) if Executive’s title is changed
from Chief Executive Officer of the Company to Chief Innovation Officer or Head of Business Development of the Company and Executive
retains duties and responsibilities substantially similar to those assigned to similar officers at comparable companies; and (B)
with respect to the Company’s acts described in clauses (a), (b) or (c) above, unless Executive shall have given written
notice to the Company within a period not to exceed ten (10) calendar days of the Executive’s knowledge of the initial existence
of the occurrence, specifying the Good Reason with reasonable particularity and, within thirty (30) calendar days after such notice,
the Company shall not have cured or eliminated the problem or thing giving rise to such Good Reason; provided, however, that no
more than two cure periods shall be provided during any twelve-month period of a breach of clauses (a), (b) or (c) above. Upon
such termination, the Company shall pay to Executive the amount set forth in Section 4.6(c).

 

    	 	5	 

    	 		 

    

 

4.5.
By Company Without Cause. The Company may terminate Executive’s employment hereunder without Cause by giving at least
thirty (30) days written notice to Executive. Upon such termination, the Company shall pay to Executive the amount set forth in
Section 4.6(c).

 

4.6.
Compensation Upon Termination. In the event that Executive’s employment hereunder is terminated, the Company shall
pay to Executive the following compensation:

 

(a)
Payment Upon Death or Disability. In the event that Executive’s employment is terminated pursuant to Sections 4.1
or 4.2, the Company shall no longer be under any obligation to Executive or his legal representatives pursuant to this Agreement
except for: (i) the Base Salary due Executive pursuant to Section 3.1 hereof through the date of termination; (ii) all valid expense
reimbursements; (iii) all accrued but unused vacation pay; and (iv) all earned and previously approved but unpaid Incentive Bonuses.

 

    	 	6	 

    	 		 

    

 

(b)
Payment Upon Termination by the Company For Cause or by Executive Without Good Reason. In the event that the Company terminates
Executive’s employment hereunder pursuant to Section 4.3, the Company shall have no further obligations to the Executive
hereunder, except for: (i) the Base Salary due Executive pursuant to Section 3.1 hereof through the date of termination; (ii)
all valid expense reimbursements; and (iii) all unused vacation pay through the date of termination required by law to be paid.

 

(c)
Payment Upon Termination by Company Without Cause or by Executive for Good Reason. In the event that Executive’s
employment is terminated pursuant to Sections 4.4 or 4.5, the Company shall have no further obligations to Executive hereunder
except for: (i) the Base Salary due Executive pursuant to Section 3.1 hereof through the date of termination; (ii) the Base Salary
at the applicable annual rate as of the date of termination for nine (9) months commencing on the date of termination or until
the end of the Term, whichever is earlier, payable in accordance with Section 3.1, subject to the Executive executing a general
release in favor of the Company; (iii) all valid expense reimbursements; (iv) all accrued but unused vacation pay; and (v) all
earned and previously approved but unpaid Incentive Bonuses.

 

(d)
No Duty to Mitigate. Executive shall have no duty to mitigate awards paid or payable to him pursuant to this Agreement,
and any compensation paid or payable to Executive from sources other than the Company will not offset or terminate the Company’s
obligation to pay to Executive the full amounts pursuant to this Agreement.

 

5.
Protection of Confidential Information; Non-Competition.

 

5.1.
Acknowledgment. Executive acknowledges that:

 

(a)
As a result of his employment with the Company, Executive has obtained and will obtain secret and confidential information concerning
the business of the Company, including, without limitation, financial information, proprietary rights, trade secrets and “know-how,”
customers and sources (“Confidential Information”).

 

    	 	7	 

    	 		 

    

 

(b)
The Company will suffer substantial damage which will be difficult to compute if, during the period of his employment with the
Company or thereafter, Executive should enter a business competitive with the Company or divulge trade secrets or other Confidential
Information.

 

(c)
The provisions of this Agreement are reasonable and necessary to protect the business of the Company, to protect the Company’s
trade secrets and Confidential Information and to prevent loss to a competitor of an employee whose services are special, unique
and extraordinary.

 

5.2.
Confidentiality. Executive agrees that he will not at any time, during the Term or thereafter, divulge to any person or
entity or use any Confidential Information obtained or learned by him as a result of his employment with the Company, except (i)
in the course of performing his duties hereunder, (ii) with the Company’s prior written consent; (iii) to the extent that
any such information is in the public domain other than as a result of Executive’s breach of any of his obligations hereunder;
or (iv) where required to be disclosed by court order, subpoena or other government process. If Executive shall be required to
make disclosure pursuant to the provisions of clause (iv) of the preceding sentence, Executive promptly, but in no event more
than 48 hours after learning of such subpoena, court order, or other government process, shall notify, confirmed by mail, the
Company and, at the Company’s expense, Executive shall: (a) take all reasonably necessary and lawful steps required by the
Company to defend against the enforcement of such subpoena, court order or other government process, and (b) permit the Company
to intervene and participate with counsel of its choice in any proceeding relating to the enforcement thereof.

 

5.3.
Documents. Upon termination of his employment with the Company, Executive will promptly deliver to the Company all memoranda,
notes, records, reports, manuals, drawings, blueprints and other documents (and all copies thereof) relating to the business of
the Company and all property associated therewith, which he may then possess or have under his control; provided, however, that
Executive shall be entitled to retain copies of such documents reasonably necessary to document his financial relationship with
the Company.

 

    	 	8	 

    	 		 

    

 

5.4.
Non-Competition. For and in consideration of the good and valuable merger consideration received by Executive pursuant
to the Agreement and Plan of Reorganization, dated as December 31, 2014, as amended as of April 23, 2015, by and among Cullen
Agricultural Holding Corp., the Company, Cullen Merger Sub, Inc., LIBB Acquisition Sub, LLC, Long Island Brand Beverages LLC and
Executive and Thomas Panza, and for and in consideration of the good and valuable consideration offered to the Executive hereunder,
Executive hereby agrees that he shall not, during the period of his employment by or with the Company and for the Applicable Period
(as defined below), for himself or on behalf of, or in conjunction with, any other person, persons, company, partnership, limited
liability company, corporation or business of whatever nature:

 

(a)
engage, as an officer, director, manager, member, shareholder, owner, partner, joint venturer, trustee, or in a managerial capacity,
whether as an employee, independent contractor, agent, consultant or advisor, or as a sales representative, in an entity that
designs, researches, develops, markets, sells or licenses products or services that are substantially similar to or competitive
with the business of the Company that is located within seventy-five (75) miles of any market in which Company currently operates
or has plans to do business in at the time of termination;

 

(b)
call upon any person who is at that time, or within the preceding twenty-four (24) months has been, an employee of the Company,
for the purpose, or with the intent, of enticing such employee away from, or out of, the employ of the Company or for the purpose
of hiring such person for Executive or any other person or entity, unless any such person was terminated by the Company more than
six (6) months prior thereto;

 

(c)
call upon any person who, or entity that is then or that has been within one year prior to that time, a customer of the Company,
for the purpose of soliciting or selling products or services in competition with the Company; or

 

(d)
call upon any prospective acquisition or investment candidate, on the Executive’s own behalf or on behalf of any other person
or entity, which candidate was known by Executive to have, within the previous twenty-four (24) months, been called upon by the
Company or for which the Company made an acquisition or investment analysis or contemplated a joint marketing or joint venture
arrangement with, for the purpose of acquiring or investing or enticing such entity into a joint marketing or joint venture arrangement.

 

    	 	9	 

    	 		 

    

 

5.5.
Injunctive Relief. If Executive commits a breach, or threatens to commit a breach, of any of the provisions of Section
5.2 or 5.4, the Company shall have the right and remedy to seek to have the provisions of this Agreement specifically enforced
by any court having equity jurisdiction, it being acknowledged and agreed by Executive that the services being rendered hereunder
to the Company are of a special, unique and extraordinary character and that any such breach or threatened breach will cause irreparable
injury to the Company and that money damages will not provide an adequate remedy to the Company. The rights and remedies enumerated
in this Section 5.5 shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under
law or equity. In connection with any legal action or proceeding arising out of or relating to this Agreement, the prevailing
party in such action or proceeding shall be entitled to be reimbursed by the other party for the reasonable attorneys’ fees
and costs incurred by the prevailing party.

 

5.6.
Modification. If any provision of Section 5.2 or 5.4 is held to be unenforceable because of the scope, duration or area
of its applicability, the tribunal making such determination shall have the power to modify such scope, duration, or area, or
all of them, and such provision or provisions shall then be applicable in such modified form.

 

5.7.
Definitions. For purposes of this Section 5:

 

(a)
the term “Company” shall be deemed to include the Company and any of its subsidiaries; and

 

(b)
the term “Applicable Period” shall mean the period commencing upon the termination of Executive’s employment
hereunder and ending on the later of (i) May 27, 2017 and (ii) one (1) year after the termination of Executive’s employment
hereunder.

 

5.8.
Survival. The provisions of this Section 5 shall survive the termination of this Agreement for any reason, except in the
event Executive is terminated by the Company without Cause, or if Executive terminates this Agreement with Good Reason, in either
of which events, clause (a) of Section 5.4 shall be null and void and of no further force or effect. The non-renewal of this Agreement
at the end of the Term shall not be deemed a termination by the Company without Cause.

 

    	 	10	 

    	 		 

    

 

6.
Miscellaneous Provisions.

 

6.1.
Notices. All notices provided for in this Agreement shall be in writing, and shall be deemed to have been duly given when
(i) delivered personally to the party to receive the same, or (ii) when mailed first class postage prepaid, by certified mail,
return receipt requested, addressed to the party to receive the same at his or its address set forth below, or such other address
as the party to receive the same shall have specified by written notice given in the manner provided for in this Section 6.1.
All notices shall be deemed to have been given as of the date of personal delivery or mailing thereof.

 

If
to Executive, to his address on file with the Company.

 

If
to the Company:

 

Long
Island Iced Tea Corp.

116
Charlotte Avenue

Hicksville,
New York 11801

Attention:
Executive Chairman

 

With
a copy in either case to:

 

Graubard
Miller

The
Chrysler Building

405
Lexington Avenue, 11th Floor

New
York, New York 10174

Attention:
David Alan Miller, Esq.; Jeffrey M. Gallant, Esq.

 

6.2.
Entire Agreement; Waiver. This Agreement sets forth the entire agreement of the parties relating to the employment of Executive
and is intended to supersede all prior negotiations, understandings and agreements. No provisions of this Agreement may be waived
or changed except by a writing by the party against whom such waiver or change is sought to be enforced. The failure of any party
to require performance of any provision hereof or thereof shall in no manner affect the right at a later time to enforce such
provision.

 

    	 	11	 

    	 		 

    

 

6.3.
Governing Law. All questions with respect to the construction of this Agreement, and the rights and obligations of the
parties hereunder, shall be determined in accordance with the law of the State of New York applicable to agreements made and to
be performed entirely in New York.

 

6.4.
Binding Effect; Nonassignability. This Agreement shall inure to the benefit of and be binding upon the successors and assigns
of the Company. This Agreement shall not be assignable by Executive, but shall inure to the benefit of and be binding upon Executive’s
heirs and legal representatives.

 

6.5.
Severability. Should any provision of this Agreement become legally unenforceable, no other provision of this Agreement
shall be affected, and this Agreement shall continue as if the Agreement had been executed absent the unenforceable provision.

 

6.6.
Section 409A. This Agreement is intended to comply with the provisions of Section 409A of the Internal Revenue Code (“Section
409A”). To the extent that any payments and/or benefits provided hereunder are not considered compliant with Section
409A, the parties agree that the Company shall take all actions necessary to make such payments and/or benefits become compliant.

 

[Signature
Page Follows]

 

    	 	12	 

    	 		 

    

 

IN
WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.

 

	Date:
    March 9, 2017	/s/
    Richard Allen
	 	Richard
    Allen
	 	Chief
    Financial Officer (Principal Financial

    Officer and Principal Accounting Officer)

 

	Date:
    March 9, 2017	/s/
    Philip Thomas
	 	Philip
    Thomas
	 	Director
    and Chief Executive Officer

    (Principal Executive Officer)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00271-of-00352.parquet"}]]